keine Finanzberatung

IQV · IQVIA Holdings Inc.

Contract research organization and healthcare-data provider for pharma

Risiko 4/10 · MODERATE RISK · leveraged trial-data engine · $267.77 ▼ 1.42%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $267.77
  • Market cap $44.1B
  • P/E (ttm) 33.35
  • Div yield none
  • 52-wk range $154.50 – $271.80
  • Index rank #120 / —

Wichtigste Risiken

  • Pharma R&D budget cuts shrink the backlog (Shareholders) — MED
  • Heavy debt load from the merger-built balance sheet (Bondholders) — MED
  • AI erodes the data-and-analytics moat (Shareholders) — MED
  • Trial cancellations if biotech funding dries up (Shareholders) — MED

Fazit

Backlog and proprietary data make it the steadiest way to own pharma R&D — as long as the leverage stays boring.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.